Compare RGEN & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGEN | BIRK |
|---|---|---|
| Founded | 1981 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.9B |
| IPO Year | N/A | 2023 |
| Metric | RGEN | BIRK |
|---|---|---|
| Price | $163.11 | $38.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $174.90 | $64.31 |
| AVG Volume (30 Days) | 597.5K | ★ 3.3M |
| Earning Date | 02-19-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.10 |
| EPS | 0.03 | ★ 2.19 |
| Revenue | $707,890,000.00 | ★ $2,460,904,611.00 |
| Revenue This Year | $17.86 | $14.14 |
| Revenue Next Year | $12.44 | $14.62 |
| P/E Ratio | $6,354.24 | ★ $18.53 |
| Revenue Growth | 11.74 | ★ 16.22 |
| 52 Week Low | $102.97 | $38.16 |
| 52 Week High | $182.52 | $62.66 |
| Indicator | RGEN | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 35.62 |
| Support Level | $158.80 | $42.12 |
| Resistance Level | $172.51 | $44.66 |
| Average True Range (ATR) | 6.24 | 1.85 |
| MACD | -0.83 | -0.32 |
| Stochastic Oscillator | 25.84 | 6.70 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.